# China Economic Capital

> China Economic Capital is a VC fund backing Energy, Medical and Hardware. See 3 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Total investments: 3
- Last investment: Dec 2023
- Lead investor: 0%
- Last updated: Aug 2026

China Economic Capital is a VC fund focused on Energy and Medical. China National Economic Capital is an investment firm.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Energy | 1 | 33% |
| Medical | 1 | 33% |
| Hardware | 1 | 33% |
| Software | 1 | 33% |
| Health Care | 1 | 33% |

9 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 1 | 33% |
| Series B | 1 | 33% |
| Venture - Series Unknown | 1 | 33% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Xingchen New Energy | Xingchen New Energy develops new generation of ultra-high-performance all-vanadium flow energy storage system, fully covering electrolyte, stack and core R&D, manufacturing and production of components, energy storage systems and other products, and provide safer comprehensive energy storage solutions. |  | Venture - Series Unknown | Dec 20, 2023 |  |
| ICE Bioscience | ICE Bioscience was founded in 2010, an Innovative CRO+ Explorer company focusing in early drug discovery services from target validation to pre-clinical candidate identification, with strong capabilities and technologies in Immunology and Oncology, Cardiovascular and CNS diseases areas. ICE Bioscience provides high professional communication andflexible collaboration models, to speed up drug discovery process better and faster.ICE Bioscience has wide target-based panel screening platform ready-to-use, we keep trying to expand diverse techniques related to Biology and Pharmacology, to support various drug discovery purpose for different indications and clinical needs, we do have quite a lot of new assays development experience and passion, to accomplish target identification and assay validation, compounds screening from hit to lead, to pre-clinical drug candidate selection. | $14M | Series B | Sep 26, 2022 |  |
| Simmir Vision Technology | Simmir Vision Technology engages in the software and hardware design of edge vision products. Simmir Vision Technology has mastered core technologies in the field of image and video processing, and currently has 12 invention patents, 4 of which are under application. | $14.4M | Series A |  |  |

3 of 3 investments shown.

## Co-investors
- [Addor Capital](https://shizune.co/investors/profile/addor-capital) — VC Fund, 1 deal together
- [CASVC](https://shizune.co/investors/profile/casvc) — VC Fund, 1 deal together
- Changzhou Industrial Fund — VC Fund, 1 deal together
- Changzhou Science and Technology Venture Capital — VC Fund, 1 deal together
- [CICC Qide](https://shizune.co/investors/profile/cicc-qide) — VC Fund, 1 deal together
- Core Capital — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does China Economic Capital invest in?

China Economic Capital invests primarily in Energy, Medical and Hardware startups, most often at Series A and Series B stage. Most of the 3 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did China Economic Capital last invest?

The most recent investment recorded for China Economic Capital closed in Dec 2023. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co